Thiol Oxidation and Loss of Mitochondrial Complex I Precede Excitatory Amino Acid-Mediated Neurodegeneration
暂无分享,去创建一个
[1] M. Rudra,et al. Inhibition of Tyrosine Aminotransferase by β‐N‐Oxalyl‐l‐α,β‐Diaminopropionic Acid, the Lathyrus sativus Neurotoxin , 1997 .
[2] F. Holsboer,et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. , 1997, Molecular pharmacology.
[3] S. Rao,et al. Inhibition of tyrosine aminotransferase by beta-N-oxalyl-L-alpha,beta-diaminopropionic acid, the Lathyrus sativus neurotoxin. , 1997, Journal of neurochemistry.
[4] J. Rothstein,et al. Therapeutic horizons for amyotrophic lateral sclerosis , 1996, Current Opinion in Neurobiology.
[5] A. F. Schinder,et al. Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity , 1996, The Journal of Neuroscience.
[6] I. Reynolds,et al. Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure , 1996, The Journal of Neuroscience.
[7] A. Ludolph,et al. Toxic models of upper motor neuron disease , 1996, Journal of the Neurological Sciences.
[8] S. Kulkarni,et al. N‐Methyl‐d‐Aspartate Receptor Participation in Parkinson's Disease, a Neurodegenerative Disorder , 1995, Annals of the New York Academy of Sciences.
[9] B. Slusher,et al. Centrally-administered AMPA antagonists increase locomotion in parkinsonian rats , 1995, Journal of neural transmission. Parkinson's disease and dementia section.
[10] N. Hattori,et al. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. , 1995, Biochimica et biophysica acta.
[11] L. R. Hill,et al. Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism , 1995, Neurology.
[12] H. Reichmann,et al. Electron transport chain defects in Alzheimer's disease. , 1994, Neurology.
[13] L. Chang,et al. Neuronal ultrastructural abnormalities in a patient with frontotemporal dementia and motor neuron disease. , 1995, Dementia.
[14] L. Scorrano,et al. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. , 1994, The Journal of biological chemistry.
[15] C. Filley,et al. Electron transport chain defects in Alzheimer's disease brain , 1994, Neurology.
[16] V. Ravindranath,et al. l-BOAA induces selective inhibition of brain mitochondrial enzyme, NADH-dehydrogenase , 1993, Brain Research.
[17] J. Walker,et al. NADH:ubiquinone oxidoreductase from bovine mitochondria. cDNA sequence of a 19 kDa cysteine-rich subunit. , 1991, The Biochemical journal.
[18] S. Shankar,et al. A simple and inexpensive slicer for preparation of brain slices , 1991, Journal of Neuroscience Methods.
[19] P. Spencer,et al. Lathyrism in rural northwestern Ethiopia: a highly prevalent neurotoxic disorder. , 1990, International journal of epidemiology.
[20] J. Coyle,et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.
[21] V. Ravindranath,et al. Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stress. , 1990, Biochemical and biophysical research communications.
[22] J. Parks,et al. Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.
[23] D. Roy,et al. β‐N‐Oxalylamino‐L‐Alanine Action on Glutamate Receptors , 1989, Journal of neurochemistry.
[24] T. Murphy,et al. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress , 1989, Neuron.
[25] D. J. Reed,et al. Retention of oxidized glutathione by isolated rat liver mitochondria during hydroperoxide treatment. , 1988, Biochimica et biophysica acta.
[26] P. Nunn,et al. Inhibition of [3H]α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding by the excitotoxin β-N-oxaly-L-α,β-diaminopropionic acid , 1988 .
[27] P. Nunn,et al. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. , 1987, Science.
[28] Q. Mohammad,et al. Lathyrism , 1939, The Lancet.
[29] P. Spencer,et al. Specific antagonism of behavioral action of “uncommon” amino acids linked to motor‐system diseases , 1987, Synapse.
[30] A. Ludolph,et al. LATHYRISM: EVIDENCE FOR ROLE OF THE NEUROEXCITATORY AMINOACID BOAA , 1986, The Lancet.
[31] S. Gibson,et al. Photosensitization of mitochondrial cytochrome c oxidase by hematoporphyrin derivative and related porphyrins in vitro and in vivo. , 1983, Cancer research.
[32] P. Nunn,et al. The neurolathyrogen, β-N-oxalyl-L-α,β-diaminopropionic acid, is a potent agonist at ‘glutamate preferring’ receptors in the frog spinal cord , 1981, Brain Research.
[33] D. Cohn,et al. Human neurolathyrism, a follow-up study of 200 patients. Part I: Clinical investigation. , 1981, Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie.
[34] S. Rao. ENTRY OF β‐OXALYL‐l‐α,β‐DIAMINOPROPIONIC ACID, THE LATHYRUS SATIVUS NEUROTOXIN INTO THE CENTRAL NERVOUS SYSTEM OF THE ADULT RAT, CHICK AND THE RHESUS MONKEY , 1978 .
[35] Y. Hatefi,et al. Preparation and properties of succinate: ubiquinone oxidoreductase (complex II). , 1978, Methods in enzymology.
[36] A. Hirano,et al. The central nervous system in a cast? of neurolathyrism , 1977, Neurology.
[37] A. Hirano,et al. The central nervous system in a case of neurolathyrism. , 1977, Neurology.
[38] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[39] F. Tietze. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. , 1969, Analytical biochemistry.
[40] T. King. [40] Preparations of succinate—cytochrome c reductase and the cytochrome b-c1 particle, and reconstitution of succinate-cytochrome c reductase , 1967 .
[41] P. Adiga,et al. The Isolation and Characterization of β-N-Oxalyl-L-α,β-Diaminopropionic Acid: A Neurotoxin from the Seeds of Lathyrus sativus* , 1964 .